Mitomycin C: a clinical update

This publication has 166 references indexed in Scilit:

• Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole
  Journal of Gastrointestinal Surgery, 1998
• Use of erythropoietin in the management of the haemolytic uraemic syndrome induced by mitomycin C/tamoxifen
  European Journal Of Cancer, 1994
• A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome
  European Journal Of Cancer, 1993
• Positive results of adjuvant mitomycin-C in resected gastric cancer: A randomised trial on 134 patients
  European Journal Of Cancer, 1993
• Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial
  European Journal Of Cancer, 1992
• Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1991
• Response to preoperative concomitant radiochemotherapy with mitomycin C and 5-fluorouracil in advanced head and neck cancer
  European Journal of Cancer and Clinical Oncology, 1989
• Mitomycin C-induced renal toxicity, a dose-dependent side effect?
  European Journal of Cancer and Clinical Oncology, 1987
• Vindesine and mitomycin C in inoperable non-small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1986
• Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neck
  European Journal of Cancer and Clinical Oncology, 1986